Jeffrey S. Hackman - 09 Aug 2022 Form 4 Insider Report for Comera Life Sciences Holdings, Inc.

Role
Chairman, President, and Chief Executive Officer., Director
Signature
/s/ Jeffrey S. Hackman
Issuer symbol
CMRA on OTC
Transactions as of
09 Aug 2022
Net transactions value
$0
Form type
4
Filing time
11 Aug 2022, 18:14:07 UTC
Previous filing
14 Feb 2023
Next filing
12 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMRA Stock Option (Right to Purchase) Award $0 +300,000 $0.000000 300,000 09 Aug 2022 Common Stock 300,000 $2.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest over four (4) years, with twenty-five percent (25%) of the shares of Common Stock underlying the option vesting on August 9, 2023 and the remainder vesting in equal monthly installments thereafter.

Remarks:

Chairman, President, and Chief Executive Officer.